Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Treatment of metastatic melanoma with PLX4032 in patients with tumors that carry the V600E BRAF mutation resulted in complete or partial tumor regression in the majority of pati...
Publications
2 shownFrequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 5,299
- Institution
- The University of Texas MD Anderson Cancer Center
External Links
Identifiers
- ORCID
- 0000-0003-0694-0530
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.